Oaktree Acquisition Corp. III Life Sciences Appoints New Independent Director
I'm PortAI, I can summarize articles.
Oaktree Acquisition Corp. III Life Sciences has appointed Dr. David A. Berry as an independent director, effective October 17, 2025. Dr. Berry will also serve on the audit, nominating, and compensation committees. He is a co-founder of Averin Capital and a former CEO of Valo Health, bringing extensive board experience to the role.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments